Clinical Trials Logo

Clinical Trial Summary

This study is a single-center prospective cohort of patients with ischemic cerebrovascular disease (ICVD) who have not met the diagnostic criteria for hypertension. Ambulatory 24-hour blood pressure monitoring (ABPM) will be performed at baseline and one year after the enrollment. The primary purpose of the study is to delineate the relationship of blood pressure variability (BPV) with the risk of composite vascular events in non-hypertensive patients with ICVD. The factors related to BPV, as well as the potential modulators of the associations between BPV and vascular risk, will be further explored among these patients.


Clinical Trial Description

Hypertension is one of the most important risk factors of ischemic cerebrovascular disease (ICVD), while various blood pressure variability (BPV) indices are immerging as novel prognostic indicators independent of the blood pressure level. However, the BPV profiles without hypertension have not been specifically observed. Considering the great importance of blood pressure management in ICVD, more research is needed to clarify whether and how BPV will increase the vascular risk in non-hypertensive patients with ICVD. This prospective cohort study will be helpful to invoke an early management of blood pressure in patients with ICVD before the clinical establishment of hypertension. All eligible non-hypertensive patients hospitalized for ICVD will be consecutively enrolled in this cohort. Blood pressure measurements are obtained with ambulatory 24-hour blood pressure monitoring (ABPM) every 20 minutes during day-time (6:00-22:00) and every 30 minutes during night-time (22:00-6:00) at baseline and one year after the enrollment. The clinical, imaging and laboratory information will be collected at baseline. During an estimated 3-year follow-up, the vessel-related diagnostic or monitoring procedures, treatment, functional status and new vascular events will be recorded by web-based patients' self-reports and investigators' regular telephone visits. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05232240
Study type Observational
Source Xuanwu Hospital, Beijing
Contact Xin Ma, MD, PhD
Phone 13501390691
Email maxin118@hotmail.com
Status Recruiting
Phase
Start date February 14, 2022
Completion date February 2028

See also
  Status Clinical Trial Phase
Recruiting NCT03589053 - Limb Remote Ischemic Conditioning and Cerebrovascular Reserve Phase 2
Enrolling by invitation NCT01925872 - Optimal Regimen in Endovascular Therapy in Ischemic Cerebrovascular Disease Based on Clopidogrel Resistance N/A
Not yet recruiting NCT03153878 - The Prospective Cohort Study on the Benefit-risk of Antithrombotic or Anticoagulant Therapy in Patients With Unruptured Intracranial Aneurysms Associated With Ischemic Heart Disease or Ischemic Cerebrovascular Disease N/A
Completed NCT02966418 - Hypoxic Preconditioning on Patients N/A
Not yet recruiting NCT06001073 - Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics
Recruiting NCT03794843 - Bioavailability Comparison Study of Two Types of Nimodipine Injections in Healthy Volunteers Early Phase 1
Not yet recruiting NCT05716646 - In the Real World Study, the Efficacy and Adverse Reactions of Ticagrelor on Ischemic Cerebrovascular Disease
Recruiting NCT03256513 - The Safety and Efficacy of Peri-procedure Blood Pressure Management of Revascularization N/A